Fmoc-D-Asp(tBu)-OH

Fmoc-D-Asp(tBu)-OH is a fluorenylmethoxycarbonyl (Fmoc) protected D-aspartic acid derivative bearing a tert-butyl ester on the side-chain carboxyl group. The molecule combines an Fmoc-protected α-amino functionality with two carboxyl-derived sites that are orthogonally protected, enabling controlled peptide coupling at the α-position while deferring side-chain reactivity. The D stereochemistry at the α-carbon supports stereochemically defined incorporation into peptide sequences and chiral structure studies, while the tBu ester is designed to withstand many coupling conditions and to be removed under acidolytic deprotection. The resulting amino acid building block participates in standard protected amino acid chemistry, including activation of the α-carboxyl group for amide bond formation and subsequent side-chain functional transformations after deprotection.

1. Peptide Synthesis

Fmoc-D-Asp(tBu)-OH is used in peptide synthesis workflows where a D-configuration aspartate residue is required for stereochemical control in peptide building block preparation. The Fmoc group enables base-mediated N-terminal protection during solid-phase or solution-phase assembly, while the α-carboxyl group and α-amino functionality support peptide coupling chemistry through standard amide bond formation strategies. The side-chain tert-butyl ester protects the β-carboxyl group during chain elongation, reducing side reactions such as undesired crosslinking or intramolecular salt formation. After selective deprotection, the liberated aspartate side chain can be carried forward for further derivatization or for generating peptides with defined acidic functionality, supporting downstream applications in peptide science and synthetic methodology development.

2. Side-Chain Functionalization

Fmoc-D-Asp(tBu)-OH is applied to side-chain functionalization programs that require orthogonal protection of the aspartate β-carboxyl group. The tBu ester provides a removable handle that can be converted into a free carboxylic acid under conditions compatible with peptide-derived intermediates, allowing controlled introduction of negative charge, salt-forming groups, or coupling-ready carboxylates. The D stereocenter can be leveraged to tune local backbone geometry and side-chain orientation in peptidomimetic structures and enzyme-binding motifs. The protected-to-deprotected sequence supports generation of functionalized Asp analogs for fragment elaboration, linker installation, and subsequent conjugation chemistry in synthetic organic chemistry and biochemical research intermediate preparation.

3. Peptidomimetics And SAR

Fmoc-D-Asp(tBu)-OH is suitable for peptidomimetic construction and structure-activity relationship studies where incorporation of D-aspartate residues helps probe stereochemical effects on binding and conformational preferences. The Fmoc-protected α-amino group and protected β-carboxyl group enable systematic library synthesis while maintaining orthogonal reactivity for stepwise modification. The presence of two carboxyl-derived functionalities supports design of hydrogen-bonding and electrostatic interactions common to aspartate-containing pharmacophores, while the D configuration can shift spatial arrangement relative to L analogs. Downstream, the resulting D-Asp-containing peptide analogs can be used as defined chemical entities for SAR mapping, molecular recognition studies, and iterative scaffold refinement in medicinal chemistry research.

4. Chemical Biology Labeling

Fmoc-D-Asp(tBu)-OH is employed in chemical biology research aimed at constructing labeled peptides and biomolecule probes with controlled acidic side-chain presentation. The protected β-carboxyl group can be unmasked after peptide assembly to generate a defined carboxylate for subsequent coupling to linkers, tags, or affinity handles through carboxyl-reactive chemistries. The Fmoc strategy supports reproducible N-terminal assembly and deprotection steps that align with multi-step probe synthesis, while the D-aspartate stereochemistry can improve resistance to proteolysis in peptide-based probes used for biochemical investigations. The resulting D-Asp-containing conjugation-ready intermediates support biomolecule modification workflows and analytical reagent generation where stereodefined peptide chemistry is required.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-D-Asp(tBu)-OH is used as a controlled stereochemical intermediate in pharmaceutical manufacturing contexts that involve peptide or peptide-like active ingredient synthesis. The Fmoc-protected amino acid format supports standardized peptide coupling and deprotection logic, aligning with process chemistry intermediate preparation for downstream bulk synthesis of protected peptide fragments. The orthogonal protection scheme, with Fmoc on nitrogen and tBu on the β-carboxyl, enables selective transformations and reduces the likelihood of premature side-chain reactions during manufacturing steps. After deprotection, the D-aspartate side chain can be carried into final API-relevant structures or into further derivatization stages, supporting scalable fine chemical synthesis of stereodefined amino acid derivatives and peptide intermediates.

1. Myotropic activity of allatostatins in tenebrionid beetles

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis